AMEX: PFNX       Pfenex Inc
Last Price Today's Change   Day's Range   Trading Volume
12.75   0.00 (0.00%)  0.00 - 0.00  0


Avg Volume (4 weeks):0
52 Weeks Range:5.26 - 14.00
52 Weeks Price Volatility (%):
Average Price Target: 16.00
Price Target Upside/Downside: +3.25


No recent Headlines for this stock.

Business Background

Pfenex is a clinical-stage biotechnology company involved in the development of protein production and bioanalytic technology. The biosimilars portfolio include PF582, for the treatment of patients with retinal diseases; PF530, designed to treat patients with multiple sclerosis; and PF708, to treat osteoporosis patients at high risk of fractures. The vaccine portfolio consists of Px563L, a novel anthrax vaccine candidate to meet U.S. government demand, funded by the U.S. Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3430  2477  343  3152 

Top 10 Active Counters
 LK 1.38+1.38 
 NIO 30.585+3.075 
 NOK 3.275-0.775 
 PINS 62.75+13.50 
 OAS 0.155-0.014 
 F 7.97+0.27 
 GE 7.396-0.024 
 AAPL 115.11+3.91 
 POLA 3.199+0.869 
 SQQQ 23.492-1.158